Comments*

 
  • Events 

    Friday, June 3, 2016 | 8:30 AM - 6:00 PM

    Antibiotics in Food: Can Less Do More?

    Speakers: Seamus Fanning (University College Dublin), Delia Grace (International Livestock Research Institute), William J. Hall (Wellcome Trust), Rebecca Irwin (Public Health Agency of Canada), Francois Malouin (Sherbrooke University), James L. Marsden (Chipotle Mexican Grill), Alan G. Mathew (Purdue University), H. Morgan Scott (Texas A&M University), Stacy E. Sneeringer (USDA), Jaap A. Wagenaar (Utrecht University), and David R. Wolfgang (Pennsylvania State University)

    Antibiotics have been used in human and animal medicine for decades. Reducing the use of antibiotics changes the dynamic between the food supply, food safety, and public health. Food safety practices may emerge a catalyst for change.

    Monday, June 13, 2016 | 10:00 AM - 3:30 PM

    2016 Ross Prize in Molecular Medicine: Resolution of Inflammation

    Speakers: Ruslan M. Medzhitov (Yale School of Medicine, Howard Hughes Medical Institute), Mauro Perretti (The William Harvey Research Institute, Queen Mary University of London), Charles N. Serhan (Brigham and Women's Hospital & Harvard Medical School), Lars Klareskog (Karolinska Institutet), and Kevin J. Tracey (The Feinstein Institute for Medical Research)

    This symposium will honor Dr. Charles N. Serhan, the recipient of the 2016 Ross Prize in Molecular Medicine, for his important discoveries in identifying bioactive mediators and cellular pathways critical in the resolution of inflammatory diseases.

    Tuesday, June 28, 2016 | 8:00 AM - 5:30 PM

    Multiple Sclerosis: Diagnostic and Treatment Frontiers

    Keynote Speaker: Giancarlo Comi (Universitè Vita-Salute San Raffaele)

    Explore novel and emerging treatments for multiple sclerosis, including biomarkers and MRI usage in disease diagnosis, prognosis, and monitoring.

    Thursday, September 8, 2016 | 8:00 AM - 5:00 PM

    Targeting Inflammation and Podocytopathy in Chronic Kidney Disease

    Speakers: Hans-Joachim Anders (Klinikum der Universität München), Caroline Fox (Merck Research Labs), John Cijiang He (The Mount Sinai Medical Center), Matthias Kretzler (University of Michigan), Kevin V Lemley (University of Southern California), Roger C. Wiggins (University of Michigan), Jochen Reiser (RUSH University)

    Accumulating evidence supports a role for renal inflammation and podocytopathy in pathogenesis and progression of chronic kidney disease. This symposium will delve into the mechanisms underlying this pathology.

  • Past Events

    Thursday, May 26, 2016 | 9:00 AM - 6:00 PM

    HIV 2016: HIV and Non-Communicable Diseases — Opportunities and Challenges

    Featured Speaker: Peter Godfrey-Faussett (UNAIDS)

    This event will address the incidence of non-communicable diseases among people living with HIV, describe morbidity and mortality, and explore interactions among HIV, antiretroviral drugs and behavioral factors influencing development and treatment.

    May 10 - 12, 2016 | United Kingdom

    Food-Microbiome Interaction: Implications for Health & Disease

    Keynote Speakers: John Bienenstock (McMaster University) and Jeffrey Gordon (Washington University in St. Louis – via Skype)

    The human body is colonized by a vast number of commensal organisms, collectively termed the microbiome. Importantly, dysbiosis — dyregulation of this endemic microbiome — has been implicated in a myriad of human diseases ranging from inflammatory bowel disease, to depression.

    April 13 - 14, 2016

    Disease Drivers of Aging: 2016 Advances in Geroscience Summit

    Keynote Speakers: Richard Hodes (National Institute on Aging and National Institutes of Health), Felipe Sierra (National Institute on Aging and National Institutes of Health), Steven Austad (University of Alabama at Birmingham), and Elissa Epel (University of California, San Francisco)

    Explore how chronic diseases — specifically HIV/AIDS, diabetes, and cancer — can affect the seven mechanistic pillars of aging.

    Tuesday, March 15, 2016 | 8:30 AM - 5:00 PM

    Advances in Human Microbiome Science: Gut-Brain Interaction

    Speakers: Premysl Bercik (McMaster University Medical Centre), John F Cryan (University College Cork), Ted Dinan (University College Cork), Emeran Mayer (David Geffen School of Medicine, UCLA), Sarkis Mazmanian (California Institute of Technology), Vassilis Pachnis, MD (The Francis Crick Institute), Robert Yolken (John Hopkins School of Medicine)

    The gut microbiome is emerging as an important regulator of brain development, brain health, and disease. This symposium will highlight recent research innovations and therapeutic applications from the microbiome with a focus on CNS health.

  • Publications 

    eBriefing

    Advances in Human Microbiome Science: Gut–Brain Interaction

    Organizers: John Hambor (Boehringer Ingelheim), Sarkis Mazmanian (California Institute of Technology), Nilufer Seth (Pfizer), Erick Young (Boehringer Ingelheim), Sonya Dougal (The New York Academy of Sciences), and Caitlin McOmish (The New York Academy of Sciences)

    This eBriefing discusses gut–brain interactions and the possibility of targeting the microbiome with a focus on CNS health.

    eBriefing

    Microbes in the City: Mapping the Urban Genome

    Keynote Speakers: Jo Handelsman (White House Office of Science and Technology Policy), W. Ian Lipkin (Columbia University), Curtis Huttenhower (Harvard T.H. Chan School of Public Health), and Coby Schal (North Carolina State University)

    This eBriefing reviews work to map the urban metagenome to probe the microbial communities in the buildings and subways, soil and sewers in our cities.

    eBriefing

    Advances in Human Microbiome Science: Intestinal Diseases

    Organizers: Mercedes Beyna (Pfizer), John Hambor (Boehringer Ingelheim), Nilufer Seth (Pfizer), Erick Young (Boehringer Ingelheim), and Sonya Dougal (The New York Academy of Sciences)
    Keynote Speaker: Stanislav Dusko Ehrlich (French National Institute for Agricultural Research; King's College London)

    This eBriefing focuses on the causal relationships between gut microbiota and intestinal health and disease.

    Annals

    B-1 Cell Development and Function

    Edited by Thomas L. Rothstein (The Feinstein Institute for Medical Research), Leonore A. Herzenberg (Stanford University School of Medicine), Nichol E. Holodick (The Feinstein Institute for Medical Research), and Eliver Ghosn (Stanford University School of Medicine)

    These papers discuss the physiological role of a unique subpopulation of B lymphocytes called B-1 cells.